Physician profile
Christine Kratch
NPI 1891316030
$2,182.45
in general payments reported to CMS, 2019-2025
34 companies · $2,053 in 2025
The $2,053 reported for 2025 was more than what 95% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $129 · 2025: $2,053.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,053.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,053.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $302.40 | 2025 | Wegovy, Ozempic, Rybelsus |
| Xeris Pharmaceuticals, INC. | $237.53 | 2025 | Recorlev, Gvoke Hypopen |
| Amgen INC. | $163.05 | 2025 | Tepezza, Repatha |
| Sequel Med Tech, LLC | $159.07 | 2025 | Twiist |
| Ascendis Pharma Endocrinology INC | $105.07 | 2025 | Yorvipath |
| Madrigal Pharmaceuticals | $101.59 | 2025 | Rezdiffra |
| Acella Pharmaceuticals, LLC | $90.13 | 2025 | NP Thyroid 60 |
| Dexcom, INC. | $70.41 | 2025 | Dexcom G6 Transmitter |
| Recordati_rare_diseases_inc. | $62.54 | 2025 | Isturisa |
| Beta Bionics, INC. | $57.89 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Tandem Diabetes Care, INC. | $57.51 | 2025 | T:Slim X2 Insulin Pump With Control-Iq |
| Antares Pharma, INC. | $56.43 | 2025 | Xyosted |
| Kiniksa Pharmaceuticals, LTD. | $52.74 | 2022 | |
| Abbvie INC. | $51.70 | 2025 | |
| Corcept Therapeutics | $49.28 | 2025 | Korlym |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merck Sharp & Dohme LLC | $49.07 | 2022 | |
| Abbott Laboratories | $46.74 | 2025 | Freestyle Libre 3 |
| Insulet Corporation | $43.29 | 2025 | Omnipod |
| Lilly USA, LLC | $41.85 | 2025 | Jardiance, Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $41.00 | 2025 | |
| Neurocrine Biosciences, INC. | $34.37 | 2025 | |
| Mannkind Corporation | $33.98 | 2025 | |
| Ibsa Pharma INC. | $32.53 | 2025 | Flector, Licart, Tirosint |
| Avvisto Therapeutics, LLC | $29.76 | 2025 | Cycloset |
| Astrazeneca Pharmaceuticals LP | $27.56 | 2022 | |
| Astellas Pharma US INC | $24.44 | 2025 | Veozah |
| Radius Health, INC. | $24.20 | 2025 | Tymlos |
| Kyowa Kirin, INC. | $22.66 | 2025 | |
| Glaxosmithkline, LLC. | $21.51 | 2025 | Arexvy, Shingrix |
| Azurity Pharmaceuticals, INC. | $19.51 | 2025 | Azmiro |
| Sanofi-Aventis U.S. LLC | $18.79 | 2025 | |
| Medtronic, INC. | $18.68 | 2025 | Minimed 780g |
| Amphastar Pharmaceuticals, INC. | $18.32 | 2025 | |
| Amneal Pharmaceuticals LLC | $16.85 | 2025 | Unithroid |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Kratch listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.